Deerfield Management Company has launched Deerfield Private Design Fund III, an investment fund that will provide private financing to healthcare companies. The new fund has approximately $1.6 billion in committed capital.
The new fund will invest in all segments of the healthcare market including biotechnology, pharmaceuticals, medical devices, healthcare services, and animal health. Financing structures include equity, debt, royalty interests, joint ventures and other structured financing alternatives.
The firm has raised and invested two prior private healthcare funds. Deerfield Private Design I invested in excess of $500 million and Deerfield Private Design II is in the final stages of committing approximately $1 billion.
“Deerfield is proud to play a leading role in advancing innovation in the development and delivery of healthcare products and services through investment, information and philanthropy. Few other industries can have such a profound impact on the quality and length of life,” said James Flynn, Managing Partner at Deerfield.
Deerfield has more than 70 experienced healthcare-focused professionals with specialized knowledge in medicine, life sciences, drug and medical device development, healthcare markets, public policy, financial instruments, tax, accounting, and corporate strategy. The firm was founded in 1994 and has offices in New York; Lausanne, Switzerland; and Shanghai, China (www.deerfield.com).
© 2014 PEPD • Private Equity’s Leading News Magazine • 4-8-14